# Novel Gallium Imaging in Hepatocellular Carcinoma

> **NCT03116945** · PHASE2 · UNKNOWN · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 18 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** 68Gallium Citrate

## Key facts

- **NCT ID:** NCT03116945
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2020-06
- **Final completion:** 2020-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2019-01-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03116945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03116945, "Novel Gallium Imaging in Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03116945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*